SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

its a Meme token and beta to Troll The "Lenny face  is a text-based emoticon, ( ͡° ͜ʖ ͡°), used to convey a range of emotions, particularly mischief, sexual innuendo, or a hidden meaning. It's often employed in online discussions to add a playful or suggestive tone to a message, or sometimes even to spam threads, according to Wikipedia. The symbol is visually interpreted as a face with two eyes (small circles), a nose (squiggly line), and a mouth (curved line).

Lenny

$LENNY is trending as community members express strong conviction and cult-like support for the meme-based cryptocurrency, emphasizing its cultural significance and resilience amidst market volatility. The community highlights $LENNY's position as an 'OG meme' and its potential for significant growth, focusing on long-term building rather than short-term hype within the Solana ecosystem.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is trending with community members highlighting its explosive momentum and resilience, particularly within the Ethereum ecosystem. Bullish sentiment is fueled by increased volume across multiple exchanges, and holders believe $YEE is carving out a strong position as the next big meme token.

Tidal Trust II - YieldMax Ultra Option Income Strategy ETF

YieldMax Ultra Option Income Strategy ETF

ULTY is trending as investors discuss its high yield and weekly distributions amidst concerns about NAV erosion and potential reverse splits. The ETF's strategy and holdings are under scrutiny, with some community members questioning its long-term viability and others remaining optimistic about income generation. News articles and social media posts highlight both the potential risks and rewards of this ultra-high yield ETF.

Trulieve Cannabis Corp. engages in the provision of medical cannabis products and services. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Quincy, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis

Trulieve Cannabis ($TCNNF) is trending amid speculation around potential cannabis rescheduling and its impact on the industry, with community members discussing the possibility of gains and strategic positioning. Some investors believe that rescheduling is near, while others express skepticism due to past disappointments. The potential for federal policy changes and the stock's perceived undervaluation are key talking points.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation and rumors surrounding potential marijuana rescheduling, with community members citing reports of a possible executive order from President Trump as soon as Monday. Discussions include the impact of rescheduling on the company, potential price targets, and the possibility of a short squeeze. The community's bullish sentiment is fueled by the potential for eased regulations and increased investment in the cannabis sector.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending amid speculation surrounding a potential SpaceX IPO and renewed interest in space infrastructure. Community discussions highlight the possibility of sector re-ratings and potential contract awards, while also weighing valuation concerns. Some investors are taking profits while others see long-term potential.

The 401jk (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and also the 401k. The 401k total holdings are valued at around $12 trillion USD and it is the most popular retirement savings plan in the US. As time passes forevermore true retirement, or as we like to call it real freedom will only become much harder and harder for people to attain.  Through meme fueled laser focus and cyperphunk ideology the 401jK meme retirement fund token and community aim to point out the absurdities of how rigged our current system is, and how only insiders and those with power are starting the benefit from the increased centralization of cryptocurrency.........while also aiming to flip the $12 trillion USD 401k system to achieve freedom before our backs and knees are breaking.

401jK

401jK is trending as community members rally around its mission to redefine retirement and challenge traditional financial systems. Bullish sentiment is fueled by the project's strong community, new exchange listings, and the belief that it addresses widespread frustration with conventional 401(k) plans. The community is actively promoting the token's vision of financial freedom through memes and content creation.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

MSOS is trending as traders discuss the potential impact of cannabis rescheduling, with many believing it could lead to significant gains. Community members are speculating on Trump's involvement and a possible executive order, while also debating the best strategies and individual stocks to capitalize on potential sector growth. Overall, there is increased optimism, but also caution due to past disappointments.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending as investors digest news from the company's AI and Autonomy Day, including the unveiling of its in-house AI chip and plans for advanced driver-assistance systems. Community chatter revolves around the potential impact on Rivian's competitive positioning against other EV manufacturers like Tesla. Some are discussing price target upgrades from analysts, while others express concern about the timeline for the tech.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

SNAP is trending as investors debate its future, with discussions around its AI partnership with Perplexity, potential for growth, and the impact of regulations like Australia's proposed social media ban for those under 16. Bullish arguments include undervaluation and potential for a turnaround, while bearish concerns focus on profitability, leadership, and the company's ability to compete.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Broadwood Partners: Leading Proxy Advisory Firm Glass Lewis Reaffirms Recommendation AGAINST STAAR Surgical Sale to Alcon

Broadwood Partners, L.P. and its affiliates (Broadwood or we) today announced that Glass, Lewis & Co., LLC (Glass Lewis), a leading independent proxy advisory firm, has reaffirmed its recommendation...

STAAR Surgical Sets the Record Straight Regarding its Robust Go-Shop Process

STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today issued the following statement to...

Broadwood Partners Comments on STAAR Surgical Board Dissent on the Revised Sale to Alcon

Broadwood Partners, L.P. and its affiliates (collectively, Broadwood, we, us or our) today reacted to the proxy statement supplement filed by STAAR Surgical Company (STAAR or the Company) (NASDAQ...

Yunqi Capital Comments on STAAR Surgicals Go-Shop Process and Alcons Revised Offer

Yunqi Capital Limited (together with its affiliates and the funds it advises, Yunqi Capital), an investment management firm and 5.1% shareholder of STAAR Surgical Company (STAAR or the Company...

<ul class="summary-bullets"><li>Alcon raised its offer to $30.75 per share after no rival bids emerged.</li><li>Broadwood said the process was flawed and STAAR is worth more than the new price.</li><li>The revised bid represents a 74% premium to STAAR’s 90-day VWAP and a 66% premium to its Aug. 4 closing price.</li></ul>Shares of STAAR Surgical Co. (STAA) climbed 10% on Tuesday after Alcon Inc. (ALC) announced an amended merger agreement that increases its cash offer for the company and reduces executive payouts.&nbsp;<h2 class="st-heading-2">Alcon Increases Bid After Go-Shop Period Ends</h2>The revision follows the expiration of STAAR’s “go-shop” period, during which no alternative proposals emerged after Alcon waived its matching rights and any breakup fee.&nbsp;Under the revised deal, Alcon will buy all remaining STAAR shares for $30.75 each, a bump that adds about $150 million to the offer and lifts the total deal value to roughly $1.6 billion. Alcon is urging shareholders to approve the transaction at the Dec. 19 meeting, saying the acquisition should start boosting earnings by the second year and is expected to close in early 2026.The revised price represents a 74% premium to STAAR’s 90-day volume-weighted average price (VWAP) and a 66% premium to its Aug.4 closing price.<h2 class="st-heading-2">Broadwood Rejects Revised Deal</h2>Broadwood Partners, which holds 30.2% of STAAR’s shares, issued a response rejecting the amended agreement and accusing the board of running what it called an “irredeemably flawed” sale process.&nbsp;The firm said the higher price only underscores the deficiencies in STAAR’s earlier negotiations, arguing that the board dismissed buyout interest from multiple parties and relied on a single bidder despite conflicts involving STAAR’s chair. Broadwood also criticized the belated go-shop, saying the terms made it nearly impossible for outside bidders to participate because they were asked to accept restrictive standstills under tight deadlines while Alcon retained oversight advantages.&nbsp;The investor reiterated longstanding concerns about executive compensation, including a previously projected $24 million payout for the CEO, saying personal incentives compromised the integrity of the process.<h2 class="st-heading-2">Investor Argues STAAR Is Undervalued</h2>In its statement, Broadwood said the latest offer does nothing to address the underlying issues and remains far below what STAAR is “worth substantially more” based on management’s own projections. It noted Alcon offered more than twice today’s price in 2024 and questioned how shareholders can trust that $30.75 is Alcon’s best and final bid.Broadwood said it has no interest in taking control of STAAR but believes the business is poised for meaningful improvement after what it described as “self-inflicted wounds” in 2024. It argued that, if projections are met, STAAR could become one of the most profitable medical technology companies globally, making the company significantly more valuable than the proposed sale price.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for both STAA and ALC was ‘bullish’, with STAA seeing ‘extremely high’ message volume and ALC drawing ‘high’ volume.One user noted, “somebody sneaky here, trying to get a better entry price, watching closely.”<stembedurl>https://stocktwits.com/mebanks/message/638601193</stembedurl>Another user said they had read claims that Broadwood had a higher offer pending and that some speculation pointed to Johnson &amp; Johnson.<stembedurl>https://stocktwits.com/timetravelBob/message/638596415</stembedurl>So far this year,&nbsp;<a href="https://stocktwits.com/symbol/STAA">STAA</a> is up 7% while&nbsp;<a href="https://stocktwits.com/symbol/ALC">ALC</a> is down 6%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

STAAR Surgical Stock Jumps 10% After Alcon Sweetens Buyout Offer — Investor Says Deal Is ‘Worth Substantially More’

STAAR rose after Alcon sweetened its offer, though Broadwood insists the company is “worth substantially more.”

Equity

Broadwood Partners Responds to Alcons Increase to Proposed Acquisition Price of STAAR Surgical

Broadwood Partners, L.P. and its affiliates (collectively, Broadwood, we, us or our) today responded to the amended transaction terms of the proposed acquisition of STAAR Surgical Company (STAAR or...

Alcon Announces Renewed STAAR Surgical Acquisition Deal At $30.75/Share In Cash

(RTTNews) - Alcon Inc. (ALC), Tuesday announced an amended merger agreement for the acquisition of STAAR Surgical Company (STAA), intending to purchase outstanding stock of the latter for $30.75 per...

Alcon Announces Amended Merger Agreement with STAAR Surgical

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an amended merger agreement for the acquisition of STAAR...

Broadwood Partners Reiterates Opposition to STAAR Surgicals Sale to Alcon Following Conclusion of Performative Go-Shop Process

Broadwood Partners, L.P. and its affiliates (collectively, Broadwood, we, us, or our) today issued the following open letter to the shareholders of STAAR Surgical Company (STAAR or the Company...

Broadwood Partners: Proxy Advisory Firm Egan-Jones Reaffirms Its Recommendation STAAR Surgical Shareholders Vote AGAINST Sale to Alcon

Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today announced that leading proxy advisory firm Egan-Jones Ratings Company (Egan-Jones) has reaffirmed its recommendation that...

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner in 1945 and is headquartered in Geneva, Switzerland.

Current Price	$78.80
Prev Close	$78.76
Open	$78.77
Dividend Yield	0.37%
50-Day Moving Average	$76.42
Beta	0.78
Avg. Volume	2.46M
PE Ratio	37.22

52-Week High	$99.20
52-Week Low	$71.55
Market Capitalization	$38.97B
EPS (Annual)	$2.06
Price to Book	1.75
Revenue Per Employee	$387,163.56
Enterprise Value/EBITDA	N/A

ALC
Alcon Inc. - Registered Shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ALC News

ALCAlcon Inc. - Registered Shares